Literature DB >> 9646447

Development and evaluation of a novel antigen capture assay for the detection of classical swine fever virus antigens.

A Clavijo1, E M Zhou, S Vydelingum, R Heckert.   

Abstract

An antigen-capture enzyme immunoassay (EIA) was developed to detect classical swine fever virus (CSFV) antigen directly from 10% w/v tissue suspension. The assay, based on the sandwich principle, uses a biotinylated monoclonal antibody bound to streptavidin-coated microplates as the capture system and a swine anti-CSFV antibody and rabbit anti-swine HRPO-conjugate as the detector system. The antigen-capture EIA was compared with conventional virus isolation and polymerase chain reaction (PCR) for detection of CSFV in tissues. The ability of the antigen-capture EIA to discriminate classical swine fever (CSF) from bovine viral diarrhea and African swine fever viruses was also tested. The assay was shown to detect 21 different strains of CSFV and was unreactive with tissues from uninfected animals. Signal to noise (S/N) ratios were calculated from the EIA absorbance values. Readings from samples positive by virus isolation (n = 47) averaged a S/N ratio of 5.34. In contrast, samples negative by virus isolation (n = 96) demonstrated a mean S/N ratio of 0.16. At S/N cut-off value of 1.0, all samples that yield virus isolation and PCR negative result were negative in the antigen-capture EIA. Compared with virus propagation in tissue culture using PK15 cells (followed by indirect peroxidase assay detection) and PCR, the EIA had a specificity of 98.7% and a sensitivity of 91.4%. The EIA is simple, can be performed in 4 h and lends itself to automation for screening of tissues sample from pigs suspected of CSFV infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9646447     DOI: 10.1016/s0378-1135(98)00160-6

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

1.  Deletions of structural glycoprotein E2 of classical swine fever virus strain alfort/187 resolve a linear epitope of monoclonal antibody WH303 and the minimal N-terminal domain essential for binding immunoglobulin G antibodies of a pig hyperimmune serum.

Authors:  M Lin; F Lin; M Mallory; A Clavijo
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Enzyme-linked immunosorbent assay based on a chimeric antigen bearing antigenic regions of structural proteins Erns and E2 for serodiagnosis of classical swine fever virus infection.

Authors:  Min Lin; Erin Trottier; Maria Mallory
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

3.  Diagnostic evaluation of a real-time reverse transcriptase PCR assay for detection of classical swine fever virus.

Authors:  G Risatti; L Holinka; Z Lu; G Kutish; J D Callahan; W M Nelson; E Brea Tió; M V Borca
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

4.  Antibody responses of pigs to defined Erns fragments after infection with classical swine fever virus.

Authors:  Min Lin; Erin Trottier; John Pasick
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

5.  Rapid detection of classical swine fever virus by a portable real-time reverse transcriptase PCR assay.

Authors:  G R Risatti; J D Callahan; W M Nelson; M V Borca
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

6.  Rapid pre-clinical detection of classical swine fever by reverse transcription loop-mediated isothermal amplification.

Authors:  Hao-tai Chen; Jie Zhang; Li-na Ma; Yan-ping Ma; Yao-zhong Ding; Xiang-tao Liu; Lei Chen; Li-qing Ma; Yong-guang Zhang; Yong-sheng Liu
Journal:  Mol Cell Probes       Date:  2008-12-13       Impact factor: 2.365

7.  Development and evaluation of an antigen-capture ELISA for detection of the UL24 antigen of the duck enteritis virus, based on a polyclonal antibody against the UL24 expression protein.

Authors:  Renyong Jia; Anchun Cheng; Mingshu Wang; Xuefeng Qi; Dekang Zhu; Han Ge; Qihui Luo; Fei Liu; Yufei Guo; Xiaoyue Chen
Journal:  J Virol Methods       Date:  2009-05-23       Impact factor: 2.014

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.